As the pandemic rages on, the other major public health crisis in recent history has not ebbed. The opioid epidemic is worsening, but providers have kept their eye on the ball and are continuing their efforts to treat opioid use disorder and curb unnecessary prescriptions. Here is a snapshot of those efforts.
Johns Hopkins Medicine is using digital health startup Emocha’s telehealth tool to monitor healthcare providers for Covid-19 symptoms. The health system had previously used Emocha’s software for other infectious diseases.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
A little more than one year after OurCrowd Qure launched a digital health fund and Luminox Health partnered with Johns Hopkins to validate medtech, a managing partner of the fund and CEO of Luminox, Dr. Yossi Bahagon, offered an update in response to emailed questions.
In a discussion at the StartUp Health Festival this week, panelists with backgrounds in hospital administration, surgery, pediatric medicine and government shared initiatives they are undertaking to focus on value with the hope that those efforts would reduce costs in the longterm.
Doctella's approach seeks to cut out the need for hospitals to hire their own software developers, adding to a growing number of health tech toolboxes as healthcare organizations seek new ways to monitor and study their patients through digital health tools.
This work from Johns Hopkins researchers could open up access to testing in remote and poor corners of the globe, according to an article published Wednesday in the journal PLoS One.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Health systems with a high profile have been expanding their brand name through collaborations around the U.S. But given the fact that some of these U.S. hospital brands can attract an international clientele, some have been making moves to expand their brand in emerging markets. Johns Hopkins Medicine’s latest move is a joint venture with […]